BANK VONTOBEL/CALL/PFIZER INC/32/0.1/17.01.25 Stock

Warrant

DE000VM9BX23

Real-time Boerse Frankfurt Warrants 04:30:41 2024-07-04 EDT
0.071 EUR +5.97% Intraday chart for BANK VONTOBEL/CALL/PFIZER INC/32/0.1/17.01.25
Current month-11.84%
1 month-47.24%
Date Price Change
24-07-04 0.071 +5.97%
24-07-03 0.067 -8.22%
24-07-02 0.073 -10.98%
24-07-01 0.082 +7.89%
24-06-28 0.076 +2.70%

Real-time Boerse Frankfurt Warrants

Last update July 04, 2024 at 04:30 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM9BX2
ISINDE000VM9BX23
Date issued 2024-01-30
Strike 32 $
Maturity 2025-01-17 (198 Days)
Parity 10 : 1
Emission price 0.13
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.155
Lowest since issue 0.051
Spread 0.01
Spread %12.05%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.7 USD
Average target price
31.92 USD
Spread / Average Target
+15.22%
Consensus